Recurrent ovarian cancers respond to cancer vaccine after 'reprogramming' with decitabine
Treatment with the drug decitabine prior to administration of chemotherapy and a cancer vaccine yielded clinical benefit for women with recurrent ovarian cancer, suggesting that this combinatorial chemoimmunotherapy may provide ...
Jan 3, 2014
0
2